ArticleCurrent computer-aided drug design2026

HOXC-AS1: A Key Biomarker for Prognosis and Immunotherapy in Lung Adenocarcinoma.

Haiyin Ye et al.PubMed ↗Publisher ↗

No numbers read from the abstract.